Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis (Q39416800)

11 September 2017

Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis (English)

1 reference

11 September 2017

Soma Mitra

1

1 reference

11 September 2017

Manoj K Chakrabarti

series ordinal

2

1 reference

11 September 2017

Hemanta Koley

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

15 May 2013

1 reference

11 September 2017

1 reference

11 September 2017

31

1 reference

11 September 2017

31

1 reference

11 September 2017

3163-3173

1 reference

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Immunology of Gut Mucosal Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

A review of vaccine research and development: human enteric infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Enteric infections and the vaccines to counter them: future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Vaccination with irradiated Listeria induces protective T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Inactivated and subunit vaccines to prevent shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Review of meningococcal group B vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): a hospital-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Live non-invasive Shigella dysenteriae 1 strain induces homologous protective immunity in a guinea pig colitis model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Release of Shiga toxin by membrane vesicles in Shigella dysenteriae serotype 1 strains and in vitro effects of antimicrobials on toxin production and release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Enterobacter sakazakii invasion in human intestinal Caco-2 cells requires the host cell cytoskeleton and is enhanced by disruption of tight junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype Enteritidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Induction of secretory immunity and memory at mucosal surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

The immune system of human milk: antimicrobial, antiinflammatory and immunomodulating properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Human milk protection against infectious diarrhea: implications for prevention and clinical care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Effect of different routes of immunization with bovine rotavirus on lactogenic antibody response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Eight genes in region 5 that form an operon are essential for invasion of epithelial cells by Shigella flexneri 2a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Optimization of virulence functions through glucosylation of Shigella LPS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.05.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2013.05.001

1 reference

11 September 2017

1 reference